FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> universal flu vaccine | Novartis | Dynavax

Dynavax inks universal vaccine pact with Novartis

  • Email
  • Print
  • Comment
  • Contact Author
  • Reprint

Dynavax Technologies and Novartis Vaccines and Diagnostics are teaming up on an effort to develop a new universal flu vaccine. Novartis Vaccines, which includes the old Chiron ops it bought out, will provide a trivalent flu vaccine to Dynavax for use in the universal vaccine in exchange for an exclusive option to negotiate a licensing deal. No financial details were divulged in their announcement.

Vaccine makers have been scrambling to come up with a universal flu vaccine that can defend against a variety of flu strains. Every year health officials target three strains--a guessing game that often misses the mark. A universal vaccine would help remove some of that guesswork and do a much better job at protecting populations

- read the report from the San Francisco Business Times

Related Articles:
Universal flu vaccine shows early promise
Acambis researching single-shot solution to flu
VaxInnate in a race to produce 'universal' flu vaccine

More stories about universal flu vaccine   Novartis   Dynavax  


Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 13 + 84?
To combat spam, please solve the math question above.